# US 10,654,814 B2 · Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 10,654,814 B2
- Document ID: US10654814B2
- Status: Granted
- Kind: B2
- Application number: 16/063,682
- Filed: 2016-11-16
- Published: 2019-09-19
- Granted: 2020-05-19
- Earliest claimed: 2015-12-22
- Assignees: Kancera AB
- Applicants: Kancera AB
- Inventors: Kristin Hammer; Mattias Jönsson; Lars Krüger
- Web page: https://patentgrep.com/patent/US10654814B2

## CPC

- C07D 263/54: Benzoxazoles; Hydrogenated benzoxazoles
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 35/00: Antineoplastic agents
- A61P 37/00: Drugs for immunological or allergic disorders
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 209/08: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C07D 235/30: Nitrogen atoms not forming part of a nitro radical
- C07D 263/57: Aryl or substituted aryl radicals
- C07D 263/58: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D 277/64: with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07D 277/66: with aromatic rings or ring systems directly attached in position 2
- C07D 307/79: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D 333/54: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D 409/04: directly linked by a ring-member-to-ring-member bond
- C07D 413/04: directly linked by a ring-member-to-ring-member bond
- C07D 413/10: linked by a carbon chain containing aromatic rings
- C07D 413/12: linked by a chain containing hetero atoms as chain links
- C07D 413/14: containing three or more hetero rings
- C07D 417/04: directly linked by a ring-member-to-ring-member bond
- C07D 471/04: Ortho-condensed systems
- C07D 487/04: Ortho-condensed systems
- C07D 491/04: Ortho-condensed systems
- C07D 495/04: Ortho-condensed systems
- C07D 498/04: Ortho-condensed systems
- A61K 31/57: substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A compound of formula (Ia) or (Ib) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of a histone deacetylase, and as such is useful in therapy, e.g. in the treatment of autoimmune disorders, mental disorders, neurodegenerative disorders, and hyperproliferative disorders.

## Claims

### Claim 1

A compound of formula (Ia) or (Ib)
or a pharmaceutically acceptable salt thereof, wherein
R1 is
wherein
each R2 is independently selected from C1-C6 alkyl, C3-C6 cycloalkyl, halogen, cyano, R3Y1-Q2, R4R5N-Q3, R6S(O)2-Q4, and
and two R2 attached to adjacent atoms of ring A1, together with the atoms to which they are attached, may form a 5- to 10-membered monocyclic or bicyclic ring, said ring optionally being substituted by one or more moieties selected from C1-C6 alkyl, C1-C6 alkoxy, halogen, and hydroxy;
R3 is selected from H, C1-C6 alkyl, R8O-Q6, and R9R10N-Q7;
R4 and R5 are independently selected from H, C1-C6 alkyl, C3-C8 cycloalkyl and R11O-Q8;
or R4 and R5, together with the nitrogen atom to which they are both attached, form a 5- or 6-membered ring, which ring is optionally substituted by one or more moieties selected from C1-C6 alkyl and R12O-Q9;
R6 is selected from H and C1-C6 alkyl;
each R7 is independently selected from C1-C6 alkyl, halogen, R13O-Q10, R14R15N-Q11, and R16S(O)2-Q12, and two R7 attached to adjacent atoms of ring A2, together with the atoms to which they are attached, may form a 5- or 6-membered ring;
R8 is selected from H and C1-C6 alkyl;
R9 and R10 are independently selected from H and C1-C6 alkyl; or R9 and R10, together with the nitrogen atom to which they are both attached, form a 5- or 6-membered ring;
each one of R11, R12 and R13 is selected from H and C1-C6 alkyl;
R14 and R15 are independently selected from H and C1-C6 alkyl; or R14 and R15, together with the nitrogen atom to which they are both attached, form a 5- or 6-membered ring;
R16 is selected from H and C1-C6 alkyl;
ring A1 and ring A2 are independently selected from phenyl and 5- or 6-membered heteroaryl;
b and c are integers of from 0 to 3;
Q1 is selected from a direct bond, C1-C3 alkylene, C2-C4 alkenylene, and Q13-Y2-Q14;
Q2 is selected from a direct bond and C1-C3 alkylene;
Q3 is selected from a direct bond, C1-C3 alkylene, and C(O);
Q4 is selected from a direct bond, C1-C3 alkylene, and NR17;
Q5 is selected from a direct bond, C1-C3 alkylene, S(O)2NR18, Q15-Y3-Q16, and
each one of Q6, Q7 and Q8 is independently selected from C1-C3 alkylene;
each one of Q9 and Q10 is independently selected from a direct bond and C1-C3 alkylene;
Q11 is selected from a direct bond, C1-C3 alkylene, and C(O);
Q12 is selected from a direct bond, C1-C3 alkylene, and NR19;
Q13 is selected from a direct bond, C1-C3 alkylene, and C1-C3 alkylene substituted by R20 and R21;
each one of Q14, Q15, Q16, Q17 and Q18 is independently selected from a direct bond and C1-C3 alkylene;
each one of R17, R18, and R19 is independently selected from H and C1-C3 alkyl;
R20 and R21 are attached to the same carbon atom and form together with the carbon atom to which they are attached a C3-C6 cycloalkyl;
Y1 is selected from O and S;
Y2 is selected from O, and NR22;
Y3 is selected from O and NR23;
R22 is selected from H, phenyl, and C1-C3 alkyl, which alkyl is optionally substituted by a substituent selected from phenyl and NR24R25;
R23 is H or C1-C3 alkyl; and
R24 and R25 are independently selected from H and C1-C3 alkyl, or R24 and R25 form, together with the nitrogen atom to which they are both attached, a 5- or 6-membered ring;
(ii) R26R27N-Q19, wherein
R26 and R27 are independently selected from H, C1-C6 alkyl and C3-C8 cycloalkyl; or R26 and R27, together with the nitrogen atom to which they are both attached, form a 5- or 6-membered ring optionally substituted by one or more moieties R28;
each R28 is independently selected from R29OC(O)NR30, and
and two R28 attached to adjacent atoms of the ring, together with the atoms to which they are attached, may form a 5- or 6-membered ring;
R29 and R30 are independently selected from H and C1-C6 alkyl;
R31 is selected from C1-C6 alkyl and halogen;
d is an integer of from 0 to 3;
ring A3 is selected from 5- to 10-membered aryl or heteroaryl;
Q19 is a direct bond or C1-C3 alkylene;
Q20 is selected from a direct bond, C1-C3 alkylene and Q21-NR32-Q22;
Q21 and Q22 are independently selected from a direct bond and C1-C3 alkylene; and
R32 is selected from H and C1-C6 alkyl; or
(iv) hydroxy-C1-C6 alkyl;
B1 is O or S;
B2 is N or CR34;
W is N or CR35;
X is N or CR36;
Z is N or CR37;
R34 is H, C1-C3 alkyl or halogen;
R35, R36 and R37 are independently selected from H and F; and
any alkyl, or cycloalkyl is optionally substituted with one or more F;
provided that when Q1 is a direct bond or C1-C3 alkylene, and ring A1 is phenyl, b is not 0; and
provided that the compound is not 2-amino-N-hydroxybenzo[d]thiazole-5-carboxamide.

### Claim 2 (depends on 1)

The compound or pharmaceutically acceptable salt of claim 1, wherein R1 is selected from
and
(ii) R26R27N-Q19,
wherein R2, b, ring A1, Q1, R26, R27 and Q19 are as defined in claim 1.

### Claim 3 (depends on 1)

The compound of claim 1, wherein b is an integer of from 1 to 3.

### Claim 4 (depends on 1)

The compound or pharmaceutically acceptable salt of claim 1, wherein R2 is selected from C1-C6 alkyl, halogen and
wherein R7, c, ring A2 and Q5 are as defined in claim 1.

### Claim 5 (depends on 1)

The compound or pharmaceutically acceptable salt of claim 1, wherein R26 and R27, together with the nitrogen atom to which they are both attached, form a 5- or 6-membered ring substituted by one moiety R28; and
R28 is
wherein R30, d, ring A3 and Q20 are as defined in claim 1.

### Claim 6 (depends on 1)

The compound or pharmaceutically acceptable salt of claim 1, wherein B2 is N.

### Claim 7 (depends on 1)

The compound or pharmaceutically acceptable salt of claim 1, wherein B1 is O.

### Claim 8 (depends on 1)

The compound or pharmaceutically acceptable salt of claim 1, wherein W is CR35, X is CR36 and Z is CR37.

### Claim 9 (depends on 1)

A compound according to claim 1, selected from
N-hydroxy-2-[4-(1-methylethyl)phenyl]-1,3-benzoxazole-5-carboxamide,
2-(4-bromophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-[3,5-bis(trifluoromethyl)phenyl]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(4-tert-butylphenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(3,4-difluorophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[3-(trifluoromethyl)phenyl]-1,3-benzoxazole-5-carboxamide,
2-(1,3-benzodioxol-5-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[4-(trifluoromethoxy)phenyl]-1,3-benzoxazole-5-carboxamide,
2-(2,6-difluorophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(4-methoxyphenyl)-1,3-benzoxazole-5-carboxamide,
2-(2-chlorophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-pyridin-3-yl-1,3-benzoxazole-5-carboxamide,
2-(2,5-dichlorophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(6-morpholin-4-ylpyridin-3-yl)-1,3-benzoxazole-5-carboxamide,
2-(3-bromophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-[4-(difluoromethoxy)phenyl]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[4-(trifluoromethyl)phenyl]-1,3-benzoxazole-5-carboxamide,
2-(3,4-dimethoxyphenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(2,5-dimethoxyphenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(2′-fluorobiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(4-pyridin-4-ylphenyl)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(4-pyridin-3-ylphenyl)-1,3-benzoxazole-5-carboxamide,
2-biphenyl-4-yl-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(2′-fluoro-3′-methoxybiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[4-(4-methoxypyridin-3-yl)phenyl]-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[4-(6-methoxypyridin-3-yl)phenyl]-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[4-(2-methoxypyridin-3-yl)phenyl]-1,3-benzoxazole-5-carboxamide,
2-(4-cyclopropylphenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[4′-(piperidin-1-ylmethyl)biphenyl-4-yl]-1,3-benzoxazole-5-carboxamide,
2-(4-aminophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(2-chloro-6-fluorophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-[4-(diethylamino)phenyl]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(2,6-dichlorophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-pyridin-2-yl-1,3-benzoxazole-5-carboxamide,
2-(4-cyanophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{4-[(methylsulfonyl)amino]phenyl}-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{4-[(phenylsulfonyl)amino]phenyl}-1,3-benzoxazole-5-carboxamide,
2-(1H-benzotriazol-5-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(2-methylpyridin-3-yl)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(6-pyrrolidin-1-ylpyridin-3-yl)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(phenylamino)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{[4-(1-methylethyl)phenyl]amino}-1,3-benzoxazole-5-carboxamide,
2-[benzyl(methyl)amino]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[(2-phenylethyl)amino]-1,3-benzoxazole-5-carboxamide,
2-(3,4-dihydroisoquinolin-2(1H)-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-{[3-(benzyloxy)phenyl]amino}-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(4-benzylpiperidin-1-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]-1,3-benzoxazole-6-carboxamide,
2-(4-fluorophenyl)-N-hydroxy-1,3-benzoxazole-6-carboxamide,
2-(4-tert-butylphenyl)-N-hydroxy-1,3-benzoxazole-6-carboxamide,
N-hydroxy-2-(4-methoxyphenyl)-1,3-benzoxazole-6-carboxamide,
2-(6-chloropyridin-3-yl)-N-hydroxy-1,3-benzoxazole-6-carboxamide,
2-(1H-benzotriazol-5-yl)-N-hydroxy-1,3-benzoxazole-6-carboxamide,
2-(2,3′-bipyridin-5-yl)-N-hydroxy-1,3-benzoxazole-6-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]-1,3-benzothiazole-6-carboxamide,
2-(1,3-benzodioxol-5-yl)-N-hydroxy-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-pyridin-4-yl-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-[4-(methylsulfonyl)phenyl]-1,3-benzothiazole-6-carboxamide,
2-(2,3-dihydro-1-benzofuran-5-yl)-N-hydroxy-1,3-benzothiazole-6-carboxamide,
2-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-hydroxy-1,3-benzothiazole-6-carboxamide,
2-(4-butylphenyl)-N-hydroxy-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-thiophen-3-yl-1,3-benzothiazole-6-carboxamide,
2-(1-benzofuran-2-yl)-N-hydroxy-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-quinolin-8-yl-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-naphthalen-2-yl-1,3-benzothiazole-6-carboxamide,
2-[3-(benzyloxy)phenyl]-N-hydroxy-1,3-benzothiazole-6-carboxamide,
2-(2-fluoro-3-methoxyphenyl)-N-hydroxy-1,3-benzothiazole-6-carboxamide,
2-(5-chloro-2-methoxyphenyl)-N-hydroxy-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]-1,3-benzothiazole-5-carboxamide,
2-(4-fluorophenyl)-N-hydroxy-1,3-benzothiazole-5-carboxamide,
2-(4-tert-butylphenyl)-N-hydroxy-1,3-benzothiazole-5-carboxamide,
N-hydroxy-2-(4-methoxyphenyl)-1,3-benzothiazole-5-carboxamide,
2-(4-fluorobenzyl)-N-hydroxy-1,3-benzothiazole-5-carboxamide,
2-(5-bromopyridin-3-yl)-N-hydroxy-1,3-benzothiazole-5-carboxamide,
N-hydroxy-2-(7-methoxy-1-benzofuran-2-yl)-1,3-benzothiazole-5-carboxamide,
2-(4-ethylphenyl)-N-hydroxy-1,3-benzothiazole-5-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl][1,3]oxazolo[5,4-b]pyridine-6-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]thieno[2,3-b]pyridine-5-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]-1-benzothiophene-6-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]-1-benzothiophene-5-carboxamide,
N-hydroxy-2-[3-(trifluoromethyl)phenyl]-1-benzothiophene-5-carboxamide,
2-[4-fluoro-3-(trifluoromethyl)phenyl]-N-hydroxy-1-benzothiophene-5-carboxamide,
N-hydroxy-2-(3-methoxyphenyl)-1-benzothiophene-5-carboxamide,
N-hydroxy-2-(4-methoxyphenyl)-1-benzothiophene-5-carboxamide,
N-hydroxy-2-(1H-pyrazol-4-yl)-1-benzothiophene-5-carboxamide,
N-hydroxy-2-(1H-indol-5-yl)-1-benzothiophene-5-carboxamide,
N-hydroxy-2-pyridin-3-yl-1-benzothiophene-5-carboxamide,
N-hydroxy-2-(2-methoxypyridin-3-yl)-1-benzothiophene-5-carboxamide,
N-hydroxy-2-(6-methoxypyridin-3-yl)-1-benzothiophene-5-carboxamide,
N-hydroxy-2-(1-methyl-1H-pyrazol-4-yl)-1-benzothiophene-5-carboxamide,
2-(3,5-dimethylisoxazol-4-yl)-N-hydroxy-1-benzothiophene-5-carboxamide,
N-hydroxy-2-[4-(trifluoromethyl)phenyl]-1-benzothiophene-5-carboxamide,
N-hydroxy-2-[4-(trifluoromethoxy)phenyl]-1-benzothiophene-5-carboxamide,
2-(4-tert-butylphenyl)-N-hydroxy-1-benzothiophene-5-carboxamide,
2-[(E)-2-(4-fluorophenyl)ethenyl]-N-hydroxy-1-benzothiophene-5-carboxamide,
2-(5-fluoro-2-hydroxyphenyl)-N-hydroxy-1-benzothiophene-5-carboxamide,
2-(5-fluoro-2-methoxyphenyl)-N-hydroxy-1-benzothiophene-5-carboxamide,
2-[3-chloro-4-(1-methylethoxy)phenyl]-N-hydroxy-1-benzothiophene-5-carboxamide,
2-[4-(dimethylcarbamoyl)phenyl]-N-hydroxy-1-benzothiophene-5-carboxamide,
N-hydroxy-2-{4-[(methylsulfonyl)amino]phenyl}-1-benzothiophene-5-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]thieno[3,2-b]pyridine-6-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]-1-benzofuran-5-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]-1-benzofuran-6-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]furo[2,3-b]pyridine-5-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]furo[3,2-b]pyridine-5-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]furo[3,2-b]pyridine-6-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)phenyl]furo[2,3-b]pyridine-6-carboxamide,
2-[(diethylamino)methyl]-N-hydroxy-1-benzofuran-6-carboxamide,
N-hydroxy-2-(1-hydroxy-1-methylethyl)-1-benzofuran-6-carboxamide,
N-hydroxy-2-(hydroxymethyl)-1-benzofuran-6-carboxamide,
2-(3,4-dimethoxyphenyl)-N-hydroxy-1-benzothiophene-6-carboxamide,
2-dibenzo [b,d]furan-4-yl-N-hydroxy-1-benzothiophene-6-carboxamide,
2-furan-3-yl-N-hydroxy-1-benzothiophene-6-carboxamide,
N-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-benzothiophene-6-carboxamide,
N-hydroxy-2-(hydroxymethyl)-1-benzofuran-5-carboxamide,
N-hydroxy-2-[6-(4-methylpiperidin-1-yl)pyridin-3-yl]-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{6-[(1-phenylethyl)amino]pyridin-3-yl}-1,3-benzoxazole-5-carboxamide,
2-{6-[(cis)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl}-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{6-[(2-methylpropyl)amino]pyridin-3-yl}-1,3-benzoxazole-5-carboxamide,
2-{6-[bis(2-methoxyethyl)amino]pyridin-3-yl}-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{6-[(pyridin-2-ylmethyl)amino]pyridin-3-yl}-1,3-benzoxazole-5-carboxamide,
2-[6-(cycloheptylamino)pyridin-3-yl]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{6-[(2R)-2-(methoxymethyl)pyrrolidin-1-yl]pyridin-3-yl}-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{6-[4-(2-methoxyphenyl)piperazin-1-yl]pyridin-3-yl}-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(6-phenylpyridin-3-yl)-1,3-benzoxazole-5-carboxamide,
2-[(3-fluorophenoxy)methyl]-N-hydroxy-1-benzofuran-5-carboxamide,
2-[(4-tert-butylphenoxy)methyl]-N-hydroxy-1-benzofuran-5-carboxamide,
N-hydroxy-2-{6-[(1-methylethyl)sulfanyl]pyridin-3-yl}-1,3-benzoxazole-5-carboxamide,
2-(4-bromo-2-fluorophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-[2-fluoro-4-(1-methylethyl)phenyl]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[3-(1-methylethyl)phenyl]-1,3-benzoxazole-5-carboxamide,
2-(4-bromo-2-morpholin-4-ylphenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(4-fluorophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[4-(1-methylethyl)-2-pyrrolidin-1-ylphenyl]-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[6-(1-methylethyl)pyridin-3-yl]-1,3-benzoxazole-5-carboxamide,
2-(4-bromo-2-ethoxyphenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(3-fluorobiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(2′,3-difluorobiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(2-fluoro-4-pyridin-3-ylphenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-[2-fluoro-4-(6-methoxypyridin-3-yl)phenyl]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(2′-methoxybiphenyl-4-yl)-1,3-benzoxazole-5-carboxamide,
2-(2′,5′-difluorobiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(5′-chloro-2′-methoxybiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[4′-(methylsulfonyl)biphenyl-4-yl]-1,3-benzoxazole-5-carboxamide,
2-[4-(3,5-dimethylisoxazol-4-yl)phenyl]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(2′-hydroxybiphenyl-4-yl)-1,3-benzoxazole-5-carboxamide,
2-(3′-fluoro-4′-hydroxybiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(5′-fluoro-2′-hydroxybiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[3′-(methylsulfonyl)biphenyl-4-yl]-1,3-benzoxazole-5-carboxamide,
2-(3-fluoro-3′,4′-dimethoxybiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-[3-fluoro-4′-(hydroxymethyl)biphenyl-4-yl]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-[3-fluoro-2′-(hydroxymethyl)biphenyl-4-yl]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(3-fluoro-4′-hydroxybiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-[4-(2,3-dihydro-1-benzofuran-5-yl)-2-fluorophenyl]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(3,3′-difluoro-2′-hydroxybiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-fluorophenyl]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(3,5′-difluoro-2′-methoxybiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[3-(piperidin-1-ylmethyl)phenyl]-1-benzothiophene-5-carboxamide,
N-hydroxy-2-(3-methoxybiphenyl-4-yl)-1,3-benzoxazole-5-carboxamide,
2-(2′-fluoro-3-methoxybiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(2′-fluoro-3,3′-dimethoxybiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[3-methoxy-4′-(1-methylethyl)biphenyl-4-yl]-1,3-benzoxazole-5-carboxamide,
2-(4′-fluoro-3-methoxybiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(4′-amino-3,3′-dimethoxybiphenyl-4-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[3-(piperidin-1-ylmethyl)phenyl]-1,3-benzoxazole-5-carboxamide,
2-(3-{[(cis)-2,6-dimethylmorpholin-4-yl]methyl}phenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(3-{[bis(2-methylpropyl)amino]methyl}phenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(3-{[cyclohexyl(methyl)amino]methyl}phenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(3-{[(2-methoxyethyl)(methyl)amino]methyl}phenyl)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[4-(piperidin-1-ylmethyl)phenyl]-1,3-benzoxazole-5-carboxamide,
2-(4-{[(2R,6S)-2,6-dimethylmorpholin-4-yl]methyl}phenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(4-{[bis(2-methylpropyl)amino]methyl}phenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{4-[(4-pyridin-4-ylpiperazin-1-yl)methyl]phenyl}-1,3-benzoxazole-5-carboxamide,
2-{4-[(tert-butylamino)methyl]phenyl}-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-[3-fluoro-4-(1-methylethyl)phenyl]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(3,4-dimethylphenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(4-propylphenyl)-1,3-benzoxazole-5-carboxamide,
2-(4-bromo-2-chlorophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(6-methoxypyridin-3-yl)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(2-methoxypyridin-3-yl)-1,3-benzoxazole-5-carboxamide,
2-(4-bromo-3-fluorophenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(4-bromo-2-methoxyphenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(3-hydroxyphenyl)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(2-hydroxyphenyl)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(2-hydroxynaphthalen-1-yl)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(4-hydroxyphenyl)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(2-phenyl-1H-imidazol-5-yl)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(2-methoxyphenyl)-1,3-benzoxazole-5-carboxamide,
2-(5-chloro-2-hydroxyphenyl)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(4-hydroxy-2-methoxyphenyl)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-(2-methyl-1H-indol-3-yl)-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[(4-propylphenyl)amino]-1,3-benzoxazole-5-carboxamide,
2-(biphenyl-3-ylamino)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-[(3-fluorophenyl)amino]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(cyclooctylamino)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[(3-methoxyphenyl)amino]-1,3-benzoxazole-5-carboxamide,
2-[(biphenyl-4-ylmethyl)amino]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[(4-methoxybenzyl)amino]-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[(4-methoxyphenyl)amino]-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[(naphthalen-1-ylmethyl)amino]-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[(2-methoxyphenyl)amino]-1,3-benzoxazole-5-carboxamide,
2-(benzylamino)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(cyclohexylamino)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-[benzyl(phenyl)amino]-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[(4-methoxybenzyl)(methyl)amino]-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{[2-(4-methoxyphenyl)ethyl]amino}-1,3-benzoxazole-5-carboxamide,
2-{(3,4-dimethoxybenzyl)[2-(dimethylamino)ethyl]amino}-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{[4-(2-morpholin-4-ylethoxy)phenyl]amino}-1,3-benzoxazole-5-carboxamide,
2-{[4-(2-ethoxyethoxy)phenyl]amino}-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{[3-(2-morpholin-4-ylethoxy)phenyl]amino}-1,3-benzoxazole-5-carboxamide,
2-{[3-(2-ethoxyethoxy)phenyl]amino}-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(4-chlorobenzyl)-N-hydroxy-1,3-benzothiazole-5-carboxamide,
N-hydroxy-2-[2-(methylsulfonyl)phenyl]-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-[3-(hydroxymethyl)phenyl]-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-[4-(hydroxymethyl)phenyl]-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-(6-methoxypyridin-3-yl)-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-(3-hydroxyphenyl)-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-(4-hydroxyphenyl)-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-[4-({[(1-methyl-1H-indol-3-yl)methyl]amino}methyl)piperidin-1-yl]-1,3-benzoxazole-5-carboxamide,
2-{4-[(benzylamino)methyl]piperidin-1-yl}-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-{[2-(1-methylethyl)phenyl]amino}-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[(2-methylphenyl)amino]-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[methyl(4-methylphenyl)amino]-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[(4-methoxyphenyl)(methyl)amino]-1,3-benzoxazole-5-carboxamide,
2-{[1-(3-fluorophenyl)cyclohexyl]amino}-N-hydroxy-1,3-benzoxazole-5-carboxamide,
N-hydroxy-2-[(4-methylphenyl)amino]-1,3-benzoxazole-5-carboxamide,
2-(diethylamino)-N-hydroxy-1,3-benzoxazole-5-carboxamide,
2-(2,6-dimethoxypyridin-3-yl)-N-hydroxy-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-[6-(1-methylethoxy)pyridin-3-yl]-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-(2-methoxypyridin-4-yl)-1,3-benzothiazole-6-carboxamide,
N-hydroxy-2-(5-methoxypyridin-3-yl)-1,3-benzothiazole-6-carboxamide,
2-{4-[(dimethylamino)methyl]phenyl}-N-hydroxy-1,3-benzothiazole-6-carboxamide,
2-[(benzyloxy)methyl]-N-hydroxy-1,3-benzothiazole-5-carboxamide,
N-hydroxy-2-(hydroxymethyl)-1,3-benzothiazole-5-carboxamide,
N-hydroxy-2-(4-pyridin-4-ylbenzyl)-1,3-benzothiazole-5-carboxamide,
N-hydroxy-2-(piperidin-1-ylmethyl)-1,3-benzothiazole-5-carboxamide,
2-{[bis(2-methylpropyl)amino]methyl}-N-hydroxy-1,3-benzothiazole-5-carboxamide,
N-hydroxy-2-({[4-(1-methylethyl)phenyl]amino}methyl)-1,3-benzothiazole-5-carboxamide,
2-(3-fluorophenyl)-N-hydroxy-1-benzofuran-5-carboxamide,
N-hydroxy-2-(6-methoxypyridin-3-yl)-1-benzofuran-5-carboxamide,
N-hydroxy-2-(4-methoxyphenyl)-1-benzofuran-5-carboxamide,
N-hydroxy-2-pyrimidin-5-yl-1-benzofuran-5-carboxamide,
N-hydroxy-2-[2-(hydroxymethyl)phenyl]-1-benzofuran-5-carboxamide,
2-{4-[(dimethylamino)methyl]phenyl}-N-hydroxy-1-benzofuran-6-carboxamide,
N-hydroxy-2-(3-hydroxyphenyl)-1-benzofuran-6-carboxamide, and
N-hydroxy-2-(3-methoxyphenyl)-1-benzofuran-6-carboxamide,
or a pharmaceutically acceptable salt thereof.

### Claim 10 (depends on 1)

A pharmaceutical composition comprising a compound according to claim 1, or a pharmaceutically acceptable salt thereof, and optionally a pharmaceutically acceptable excipient.

### Claim 11 (depends on 1)

A combination product comprising a compound according to claim 1, or a pharmaceutically acceptable salt thereof, and a further therapeutic agent.

### Claim 12 (depends on 11)

The combination product according to claim 11, wherein the further therapeutic agent is an agent useful in the treatment an autoimmune disorder, a mental disorder, a neurodegenerative disorder, or a hyperproliferative disorder.

### Claim 13 (depends on 11)

The combination product according to claim 11, wherein the further therapeutic agent is dexamethasone.

### Claim 14 (depends on 1)

A method of treatment of a disorder selected from an autoimmune disorder, a mental disorder, a neurodegenerative disorder, or a hyperproliferative disorder which method comprises administration of a therapeutically effective amount of a compound according to claim 1 or a pharmaceutically acceptable salt thereof, to a mammal having said disorder.

### Claim 15 (depends on 14)

The method of claim 14, wherein the compound or pharmaceutically acceptable salt thereof is administered in combination with a further therapeutic agent.

### Claim 16 (depends on 15)

The method of claim 15, wherein the further therapeutic agent is dexamethasone.
